Clinical Trial Update: Phase II Randomized Study of Alendronate Sodium for Osteopenia in Patients With Gaucher's Disease [Phase 2]

View source ↗

Summary

Phase II randomized trial of alendronate for osteopenia in Gaucher disease patients completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease
• Osteopenia

Drugs mentioned

• ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Gaucher's Disease, Osteopenia | Phase 2 | Status: COMPLETED